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Ab s t r a c t
Introduction: Vacuum-assisted core biopsy (VACB) guided by ultrasound is a minimally invasive method used in diag-
nosis and treatment of breast focal lesions. Vacuum-assisted core biopsy is an interesting minimally invasive alterna-
tive to open surgical biopsy.
Aim: To assess the value of ultrasound-guided vacuum-assisted core biopsy in the diagnosis and treatment of breast
focal lesions.
Material and methods: In the period 2009-2010, 397 ultrasound-guided vacuum-assisted core biopsies were per-
formed. Mean age of the patients was 41.7 years (18-92 years), and size of the lesions ranged from 3 mm to 65 mm,
mean size being 12 mm. All women with diagnosed atypical ductal hyperplasia or cancer were qualified for surgery.
The patients with histopathologically benign lesions were under follow-up. 
Results: Samples sufficient for histopathological examination were obtained from 394 cases (99.2%). Of all 
397 lesions, 293 (73.7%) were diagnosed as benign, there were 6 (1.6%) cases of atypical ductal hyperplasia and 
98 (24.7%) malignant lesions. Three hundred and sixty-nine lesions were below 15 mm in diameter, of which 339 (91.9%)
were totally removed during the VACB. 
Conclusions: The results obtained confirm high efficiency of ultrasound-guided VACB in the differential diagnosis of
breast focal lesions, including impalpable ones. It is a safe method with a low complication rate. In the case of benign
lesions with a diameter not exceeding 15 mm, it allows one to excise the whole lesion and is a very good alternative
to an open surgical biopsy. Vacuum-assisted core biopsy should be a standard and the method of choice in diagnos-
ing breast lesions.
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Introduction
Vacuum-assisted core biopsy (VACB), also known
as mammotome biopsy, is a minimally invasive
method used in diagnosis and treatment of breast
focal lesions. Vacuum-assisted core biopsy was first
performed on the 5th of August, 1995 in Denver, USA.
Since 1996 it has been used in Europe and since 1999
in Poland [1]. Mammotome biopsy can be performed
under the guidance of ultrasound or mammography
(stereotaxic biopsy), and recently also under MR guid-
ance [2]. Various advantages of VACB have made it
a commonly used procedure in diagnosing breast
lesions [3, 4]. It is a safe, well tolerated by patients
and minimally invasive method that does not require
hospital stay. It causes minimal to no scarring and
does not deform the breast. Vacuum-assisted core
biopsy allows removal of multiple tissue samples in
a single attempt in a relatively short time and the
patient is able to quickly return to work.
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Vacuum-assisted core biopsy is primarily a diag-
nostic method. Focal lesions in the breast requiring
histopathological examination are the primary indi-
cation for this procedure. In some cases, the method
can be used therapeutically. It is not used to treat
malignant lesions because the samples obtained in
this way are fragmented, which makes it impossible
to precisely establish the margin of removed tissue.
However, with small benign lesions, the method is
currently an interesting minimally invasive alterna-
tive to open surgical biopsy [5].
Aim
The aim of this study is to assess the value of
ultrasound-guided vacuum-assisted core biopsy in the
diagnosis and treatment of breast focal lesions.
Material and methods 
We analyzed the results of 397 ultrasound-guided
vacuum-assisted core biopsies performed in 2009-
2010 in the Regional Out-patient Clinic of Early Diag-
nosis and Treatment of Breast Diseases at the Clinical
Ward of General, Oncological and Gastroenterological
Surgery of the University Hospital in Krakow. 
All women enrolled in the study underwent ultra-
sonographic examination and women over 40 years
of age also underwent mammography. All breast
lesions were classified ultrasonographically as BIRADS
category 3, 4a, 4b, 4c, 5. Ultrasonographic examina-
tion was performed with LOGIQ 5 equipment using
a 10 MHz linear probe. Before each biopsy blood clot-
ting parameters were checked. A 2-3 mm incision in
the skin was made before inserting a 10G needle
(Encor). The mean number of samples obtained from
a single insertion was 9 (5–17). Biopsy was performed
with the patient laying on her back under local anes-
thesia with 1% Lignocaine prior to the start of the pro-
cedure. The procedure lasted from 10 min to 20 min.
Compression of approximately 5 min duration was
used immediately following the removal of the biopsy
device. No sutures were used. Pressure dressing was
used routinely over the breast for 24 h following the
procedure. All vacuum-assisted core biopsies and sur-
gical excisions were performed by the same experi-
enced surgeons. A pathologist examined the samples
in the laboratory of the Chair of Pathomorphology of
the Jagiellonian University Medical College. 
Vacuum-assisted core biopsy was used to obtain
histopathological diagnosis of the breast lesions.
Therapeutic excision of lesions up to 15 mm in diam-
eter with low risk of malignancy (BIRADS category 3
and 4a) was done routinely during the biopsy. In case
of suspected malignant lesions biopsy verified the
diagnosis and defined the receptor status of the
tumor, necessary for optimal planning of the treat-
ment. Whenever there was a high suspicion of
a malignant process (BIRADS category 4b, 4c, 5) and
the diameter of the lesion was less than 10 mm, gel-
titanium breast tissue marker was used as a routine
measure.
The patients with histopathological diagnosis of
benign lesions were followed up with clinical and
ultrasound examination after 3 and 6 months, and
then annually. All women with atypical ductal hyper-
plasia (ADH), ductal carcinoma in situ (DCIS) or inva-
sive cancer were qualified for surgical excision.
The follow-up period ranged from 14 to 38 months,
25 months on average. Patients who refused to give
informed consent to VACB, had allergy to local anes-
thetics, and those with active skin infections on the
breast were disqualified.
Results
The mean age of the patients was 41.7 years 
(18-92 years). The size of the biopsied lesions ranged
from 4 mm to 65 mm (mean: 12 mm). The analyzed
parameters including the location of the lesion in the
breast, clinical features, as well as ultrasonographic
and histopathological findings, are shown in Table I.
Morphology of breast lesions qualified for ultra-
sound-guided VACB and their classification according
to BIRADS are shown in Table II.
During the first biopsy, an adequate number of
samples for the histopathological examination was
obtained from 394/397 patients (99.2%). In 3 cases
the result was nondiagnostic. These patients under-
went repeat biopsy and histopathological examina-
tion revealed fibrocystic lesions. Among 397 focal
lesions detected, there were 293 (73.7%) benign
lesions, 6 cases of atypical hyperplasia (1.6%), and 
98 malignant lesions (24.7%). Of all 98 cancers diag-
nosed by biopsy, 28 were impalpable (28.6%).
Of 369 lesions below 15 mm in diameter, 339
(91.9%) were entirely removed during VACB. Excision
was incomplete in 30 patients with benign lesions
(22 fibroadenomas, 6 fibrocystic lesions, 2 hyper-
plas tic lesions without atypia) and no recurrence or
malignant process was revealed in the follow-up. 
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In 98 women breast cancer diagnosis was made
based on the histopathological findings from the first
VACB samples. Three women, due to the lack of corre-
lation between the clinical manifestations, ultrasound
and histopathological findings were qualified for an
open surgical biopsy and cancer diagnosis was con-
firmed (Table III). False negative results were obtained
from 3/98 patients (2.3%) who underwent VACB. 
Patients diagnosed with atypical ductal hyperpla-
sia or cancer on VACB were qualified for surgical
excision. Of 6 patients diagnosed with ADH, 2 were
diagnosed with ductal carcinoma in situ. Surgical
biopsy revealed an underestimation of 2/6 (33.3%).
Of 12 pa tients with ductal carcinoma in situ, 2 were
diagnosed with invasive cancer. Underestimation of
DCIS was 2/12 (16.7%). Histopathological findings of
the patients are summarized in Table IV.
Clinical and morphological features of the biopsied breast lesions No. of patients Percentage of patients
Right breast 190 48
Left breast 207 52
Superior lateral quadrant 163 41
Superior medial quadrant 79 20
Inferior lateral quadrant 131 33
Inferior medial quadrant 24 6
Size of lesion (longest size in ultrasound) [mm]:
< 15 369 92.9
> 15 28 7.1
Impalpable lesion 358 90.1
Palpable lesion 39 9.9
Histopathological diagnosis:
Fibrocystic lesions 82 20.6
Fibroadenoma 131 33.0
Sclerosing adenosis 23 5.8
Papilloma 11 2.7
Hamartoma 1 0.3
Hyperplasia without atypia 42 10.5
Atypical ductal hyperplasia (ADH) 6 1.6
Ductal carcinoma in situ (DCIS) 12 3.0
Invasive ductal cancer 80 20.1
Invasive lobular cancer 6 1.6
Nondiagnostic result 3 0.8
Table I. Clinical and morphological features of the biopsied breast lesions




Complex cyst 14 3.6
Total 397 100
BIRADS 3 17 4.3
BIRADS 4a 291 73.3
BIRADS 4b 10 2.5
BIRADS 4c 6 1.2
BIRADS 5 80 18.5
Total 397 100
Table II. Morphology of breast lesions qualified
for VACB and their BIRADS classification
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In the first 24 h after the biopsy the patients under-
went ultrasound examination which detected he -
matoma in the biopsy site in 37/397 women (9.3%),
ranging from 8 mm to 34 mm (mean: 16 mm). None of
the hematomas required surgical intervention.
Discussion
Breast cancer is the most common malignant
neoplasm in women in Poland and the second most
frequent cause of death due to malignant neoplasm
in this group. Developments in imaging diagnostics
and relatively good availability of mammography and
ultrasound increased detection of breast focal lesions
in the pre-clinical stage. The differential diagnosis of
small, impalpable focal lesions suspected of a malig-
nant process is especially difficult. Until recently, the
golden standard in such cases was an open surgical
biopsy. However, possible complications, the length
of the procedure, high costs, scars, and frequently
breast deformation have led to a search for less inva-
sive and less expensive methods. Vacuum-assisted
core biopsy proves to be a method that eliminates or
to a large extent limits these disadvantages [6-8]. It is
an efficient, minimally invasive, relatively inexpensive
procedure with a good cosmetic effect and a low
complication rate [9-13]. 
Similarly to minimally invasive techniques used in
the treatment of other organs, VACB is in some cases
an interesting alternative to a more extended surgical
procedure [14, 15]. This procedure is gradually taking
over the so far commonly used fine needle aspiration
biopsy whose main disadvantage is a high rate of
nondiagnostic results (4-35.4%) and false negative
results (2.6-20%) [6, 16-18]. Vacuum-assisted core
biopsy provides multiple quality samples from a single
insertion compared to a traditional core biopsy [2, 7].
The diagnostic accuracy of the mammotome biopsy is
98-100% for breast lumps [1, 6, 19]. The open surgical
biopsy yields similar results, but it is more invasive
and costly. In our patients, a sufficient number of
samples for histopathological examination was
obtained in the first biopsy from 394 patients (99.2%).
Only in 3 cases (0.8%) was the result nondiagnostic.
Repeat breast biopsy in these cases revealed fibro-
cysts. Our results were consistent with the observa-
tion of other authors. For example, in his study, Cas-
sano et al. obtained a sufficient number of samples
for histopathological verification in the first ultra-
sound-guided biopsy from all 404 of his patients [20].
Women diagnosed with a benign lesion (fibroade -
noma, fibrocysts, adenosis, papillomas, hyperplasia
without atypia) without a suspected malignant
process in imaging examinations were followed up for
several months with mammograms, digital mammo-
grams, ultrasound, or MR. In none of the cases was
a recurrence or progress revealed, which confirms
that further verification with an open surgical biopsy
was not necessary in these cases. Our observations
Case Ultrasound Diameter BIRADS VACB Open surgical biopsy
1 Hypoechogenic nodule 10 mm × 8 mm 4c Sclerosing adenosis Invasive lobular cancer
2 Distortion 9 mm × 6 mm 4c Unspecific Invasive ductal cancer
inflammatory lesions
3 Hypoechogenic nodule 14 mm × 7 mm 5 Fibrosis Invasive ductal cancer
Table III. Clinical and pathological features of breast cancers in patients with false negative result of VACB
Histopathological  No. of patients Histopathological findings after No. of patients Underestimation [%]
findings after VACB open surgical biopsy
ADH 6 Hyperplasia without atypia 4 33.3
DCIS 2
DCIS 12 DCIS 10 16.7
Invasive cancer 2
Table IV. Cases of ADH and DCIS on VACB that were upgraded to DCIS or invasive cancer on surgical excision
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are in this respect consistent with those of other
authors [5, 6, 18, 20-22].
An ultrasound-guided vacuum-assisted core
biopsy can have therapeutic value. It gives excellent
cosmetic results, is well tolerated and is associated
with low complication rates compared to surgery
[20]. In our study, we entirely removed in ultrasound-
guided VACB all lesions with low risk of malignancy
in imaging examinations with a diameter up to
15 mm in 94.5% of women, similarly as Plantade,
who excised entire lesions in 98.1% of his patients
[23]. However, if the patients are diagnosed with
a benign lesion during the biopsy and the lesions are
classified as BIRADS 4b, 4c, 5 in imaging examina-
tions, it is necessary to repeat the biopsy or perform
open surgical biopsy [20, 24] due to a high risk of
overlooking cancer. In our patients, 2 lesions were
classified as BIRADS 4c, and 1 BIRADS 5 tumor was
found to be benign on biopsy (Table IV), although the
final diagnosis established after surgical biopsy was
invasive cancer.
Atypical ductal hyperplasia (ADH) is a proliferative
lesion that often coexists with breast cancer and sub-
stantially increases the risk of breast cancer. In other
studies, the number of diagnosed breast cancer cas-
es after surgery in patients who were earlier diag-
nosed with ADH in VACB reaches 68% [25], compared
to 33.3% in our group. Of our 12 patients diagnosed
with ductal carcinoma in situ by VACB, surgical biop-
sy revealed invasive cancer in 2 cases (underestima-
tion was 16.7%). These results confirm the necessity
of surgery in ADH and DCIS patients who underwent
ultrasound-guided mammotome biopsy.
Of 98 breast cancer cases diagnosed by biopsy, 
28 were impalpable. The results indicate high value
of ultrasound-guided VACB in diagnosis of the pre-
clinical stage of breast cancer. In case of suspected
malignant lesions, VACB allows one to verify the diag-
nosis and define the receptor status [6]. It helps to
make correct a therapeutic decision whether to
administer systemic palliative treatment or induction
therapy. Complications after vacuum-assisted core
biopsy are rare, ranging from 1.3% to 9% [6, 23, 24].
The most common, hematoma in the biopsy site,
occurred in 7.3% of our patients. None of them
required surgical intervention. We did not observe
any complications described in the literature, such as
hemorrhage from the biopsy site, hematomas requir-
ing a revision, pneumothorax, damage to skin away
from the needle puncture point or infections.
Conclusions
The results obtained from our study confirm high
efficiency of ultrasound-guided VACB in the differen-
tial diagnosis of breast focal lesions, including impal-
pable lesions. It is a safe method with a low compli-
cation rate and a useful alternative to the open
surgical biopsy for benign lesions with a diameter not
exceeding 15 mm. Vacuum-assisted core biopsy is
therefore recommended as a standard and a method
of choice in the diagnosis of breast lesions. 
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